Cargando…
Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics
BACKGROUND: Pharmacokinetic and pharmacodynamic (PK/PD) indices are increasingly being used in the microbiological field to assess the efficacy of a dosing regimen. In contrast to methods using MIC, PK/PD-based methods reflect in vivo conditions and are more predictive of efficacy. Unfortunately, th...
Autores principales: | Bi, Goue Denis Gohore, Li, Jun, Nekka, Fahima |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709609/ https://www.ncbi.nlm.nih.gov/pubmed/19558679 http://dx.doi.org/10.1186/1742-4682-6-10 |
Ejemplares similares
-
Trapezoid bioequivalence: A rational bioavailability evaluation approach on account of the pharmaceutical‐driven balance of population average and variability
por: Soufsaf, Sara, et al.
Publicado: (2022) -
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations
por: Aljutayli, Abdullah, et al.
Publicado: (2022) -
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination
por: Fenneteau, Frédérique, et al.
Publicado: (2009) -
Antimicrobial Resistance: Beyond the Breakpoint
por: Pombo, David J.
Publicado: (2010) -
Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
por: Sarem, Sarem, et al.
Publicado: (2014)